StockDrifts LogoStockDrifts

Resense Medical 394420

Company
리센스메디컬Resense Medical
Insiders
0
Buys
0
Total Value
—
Avg Return
—
Last Filing
2026-06-26

Resense Medical (394420) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Resense Medical is dated 2026-03-31; the most recent is 2026-06-26. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-06-26BUY주식매수선택권
김세왕
Kim Se-wang
Managing Director10.7K₩15,940+5.4%₩171M ($119K)
2026-03-31BUY신규상장
김건호
Kim Geon-ho
Co-CEO2.2M---

Frequently asked questions

Who has been buying Resense Medical stock?
0 distinct insiders have filed 0 disclosed insider purchases in Resense Medical (394420), most recently on 2026-06-26. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Resense Medical have?
Resense Medical has 0 buy-side and 0 sell-side disclosures on record, spanning 2026-03-31 to 2026-06-26.
Where does StockDrifts get Resense Medical insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Resense Medical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.